Diseases & Conditions market research reports by Global Markets Direct

• Haemophilus Influenzae Type B Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jul 29, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Haemophilus Influenzae Type B Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Haemophilus influenzae Type B Infections - Drugs In Development, 2022, pro ... Read More

• Binge Eating Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jul 29, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Binge Eating Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Binge Eating Disorder - Drugs In Development, 2022, provides an overview of the Binge Eating ... Read More

• Osteoarthritis Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jul 29, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Osteoarthritis Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis Pain - Drugs In Development, 2022, provides an overview of the Osteoarthritis Pa ... Read More

• Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jul 29, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Drugs In Development, 2022, provides an overview of the Allergic Rhinitis (Re ... Read More

• Guillain-Barre Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jul 29, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Guillain-Barre Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Guillain-Barre Syndrome - Drugs In Development, 2022, provides an overview of the Guillain- ... Read More

• Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jul 29, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Drugs In Development, 2022, provides an overview of the Hepatitis D (Infectious Disease) ... Read More

• Low Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jul 29, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Low Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Low Back Pain - Drugs In Development, 2022, provides an overview of the Low Back Pain (Central Nervou ... Read More

• Peanut Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jul 29, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Peanut Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Drugs In Development, 2022, provides an overview of the Peanut Allergy (Immunology) ... Read More

• Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jul 29, 2022  |  Published by: Global Markets Direct  |  USD 2,500

  Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Drugs In Development, 2022, provides an overview of the Pancreatic Cancer (On ... Read More

• Proliferative Diabetic Retinopathy (PDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Proliferative Diabetic Retinopathy (PDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Diabetic Retinopathy (PDR) – Drugs In Development, 2022, pro ... Read More

• Herpes Zoster (Shingles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Herpes Zoster (Shingles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Herpes Zoster (Shingles) – Drugs In Development, 2022, provides an overview of the Herpes ... Read More

• Esophageal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 2,500

  Esophageal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Esophageal Cancer – Drugs In Development, 2022, provides an overview of the Esophageal Cancer (On ... Read More

• Huntingtin (Huntington Disease Protein or HTT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 3,500

  Huntingtin (Huntington Disease Protein or HTT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'Huntingtin – Drugs In Development, 2022'; Huntingtin (Huntington Disease Protein or H ... Read More

• Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveal Melanoma – Drugs In Development, 2022, provides an overview of the Uveal Melanoma (Oncology) p ... Read More

• Human Papillomavirus (HPV) Associated Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 2,500

  Human Papillomavirus (HPV) Associated Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer – Drugs In Development, 2 ... Read More

• Hepatitis C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 2,500

  Hepatitis C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C – Drugs In Development, 2022, provides an overview of the Hepatitis C (Infectious Disease) ... Read More

• Celiac Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Celiac Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Celiac Disease – Drugs In Development, 2022, provides an overview of the Celiac Disease (Gastrointes ... Read More

• Hemophilia B (Factor IX Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Hemophilia B (Factor IX Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hemophilia B – Drugs In Development, 2022, provides an overview of the Hemophi ... Read More

• Alcoholic Hepatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Alcoholic Hepatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alcoholic Hepatitis – Drugs In Development, 2022, provides an overview of the Alcoholic Hepatit ... Read More

• Psoriasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 2,500

  Psoriasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis – Drugs In Development, 2022, provides an overview of the Psoriasis (Immunology) pipeline lands ... Read More

• Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  Jun 30, 2022  |  Published by: Global Markets Direct  |  USD 2,500

  Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritoneal Cancer – Drugs In Development, 2022, provides an overview of the Peritoneal Cancer (On ... Read More

• Human Immunodeficiency Virus (HIV) Infections (AIDS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  May 31, 2022  |  Published by: Global Markets Direct  |  USD 2,500

  Human Immunodeficiency Virus (HIV) Infections (AIDS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus (HIV) Infections (AIDS) - Drugs I ... Read More

• Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  May 31, 2022  |  Published by: Global Markets Direct  |  USD 2,000

  Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Anemia - Drugs In Development, 2022, provides an overview of the C ... Read More

• Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  May 31, 2022  |  Published by: Global Markets Direct  |  USD 2,500

  Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Depression - Drugs In Development, 2022, provides an overview of the Depression (Central Nervous System) ... Read More

• Influenza A Virus, H1N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  May 31, 2022  |  Published by: Global Markets Direct  |  USD 2,500

  Influenza A Virus, H1N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections - Drugs In Development, 2022, ... Read More

< prev 1 2 3 4 5 6 next >